The immune response to infection in the bladder.

Autor: Lacerda Mariano L; Department of Immunology, Institut Pasteur, Paris, France.; Inserm, U1223, Paris, France., Ingersoll MA; Department of Immunology, Institut Pasteur, Paris, France. molly.ingersoll@pasteur.fr.; Inserm, U1223, Paris, France. molly.ingersoll@pasteur.fr.
Jazyk: angličtina
Zdroj: Nature reviews. Urology [Nat Rev Urol] 2020 Aug; Vol. 17 (8), pp. 439-458. Date of Electronic Publication: 2020 Jul 13.
DOI: 10.1038/s41585-020-0350-8
Abstrakt: The bladder is continuously protected by passive defences such as a mucus layer, antimicrobial peptides and secretory immunoglobulins; however, these defences are occasionally overcome by invading bacteria that can induce a strong host inflammatory response in the bladder. The urothelium and resident immune cells produce additional defence molecules, cytokines and chemokines, which recruit inflammatory cells to the infected tissue. Resident and recruited immune cells act together to eradicate bacteria from the bladder and to develop lasting immune memory against infection. However, urinary tract infection (UTI) is commonly recurrent, suggesting that the induction of a memory response in the bladder is inadequate to prevent reinfection. Additionally, infection seems to induce long-lasting changes in the urothelium, which can render the tissue more susceptible to future infection. The innate immune response is well-studied in the field of UTI, but considerably less is known about how adaptive immunity develops and how repair mechanisms restore bladder homeostasis following infection. Furthermore, data demonstrate that sex-based differences in immunity affect resolution and infection can lead to tissue remodelling in the bladder following resolution of UTI. To combat the rise in antimicrobial resistance, innovative therapeutic approaches to bladder infection are currently in development. Improving our understanding of how the bladder responds to infection will support the development of improved treatments for UTI, particularly for those at risk of recurrent infection.
Databáze: MEDLINE
Externí odkaz: